The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 23033255 |
177 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors. |
Tongji University |
| 22328583 |
132 |
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity. |
Pfizer |
| 22930276 |
25 |
Predicting the drug interaction potential of AMG 853, a dual antagonist of the D-prostanoid and chemoattractant receptor-homologous molecule expressed on T helper 2 cells receptors. |
Amgen |
| 22168898 |
10 |
Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications. |
Merck Research Laboratories |
| 20472432 |
29 |
Rapid synthesis of an array of trisubstituted urea-based soluble epoxide hydrolase inhibitors facilitated by a novel solid-phase method. |
Boehringer Ingelheim Pharmaceuticals |
| 19969453 |
73 |
Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase. |
Boehringer Ingelheim Pharmaceuticals |
| 19746975 |
67 |
Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase. |
Boehringer Ingelheim Pharmaceuticals |
| 16495056 |
23 |
Design and synthesis of selective, high-affinity inhibitors of human cytochrome P450 2J2. |
Universite Paris 5 René |
| 29138024 |
213 |
(E)-3-(3,4,5-Trimethoxyphenyl)-1-(pyridin-4-yl)prop-2-en-1-one, a heterocyclic chalcone is a potent and selective CYP1A1 inhibitor and cancer chemopreventive agent. |
De Montfort University |
Search and Browse
